{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T04:03:44Z","timestamp":1747541024436,"version":"3.40.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"DOI":"10.7759\/cureus.84262","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T06:32:21Z","timestamp":1747463541000},"source":"Crossref","is-referenced-by-count":0,"title":["Pattern Distribution and Utility of Reporting Anticellular Antibody Over Antinuclear Antibody: An Initial Report From the Immunofluorescence Laboratory of North Bengal Medical College and Hospital, West Bengal"],"prefix":"10.7759","author":[{"given":"Ushasi","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arghya","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasenjit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivy","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishek","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhiman","family":"Sardar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saheli","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utpal","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.3.3.190","article-title":"Serologic testing in connective tissue diseases","volume":"3","author":"Habash-Bseiso DE","year":"2005","unstructured":"Habash-Bseiso DE, Yale SH, Glurich I, Goldberg JW. Serologic testing in connective tissue diseases. Clin Med Res. 2005, 3:190-3. 10.3121\/cmr.3.3.190","journal-title":"Clin Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12691\/ijcd-3-4-8","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner A","year":"2015","unstructured":"Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2015, 3:151-5. 10.12691\/ijcd-3-4-8","journal-title":"Int J Celiac Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.103235","article-title":"The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review","volume":"44","author":"Chandrashekara S","year":"2012","unstructured":"Chandrashekara S. The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review. Indian J Pharmacol. 2012, 44:665-71. 10.4103\/0253-7613.103235","journal-title":"Indian J Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.41214","article-title":"Increasing prevalence of antinuclear antibodies in the United States","volume":"72","author":"Dinse GE","year":"2020","unstructured":"Dinse GE, Parks CG, Weinberg CR, et al.. Increasing prevalence of antinuclear antibodies in the United States. Arthritis Rheumatol. 2020, 72:1026-35. 10.1002\/art.41214","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2134-1","article-title":"Antinuclear antibody positive autoimmune disorders in North India: an appraisal","volume":"32","author":"Minz RW","year":"2012","unstructured":"Minz RW, Kumar Y, Anand S, Singh S, Bamberi P, Verma S, Shegal S. Antinuclear antibody positive autoimmune disorders in North India: an appraisal. Rheumatol Int. 2012, 32:2883-8. 10.1007\/s00296-011-2134-1","journal-title":"Rheumatol Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-020-00925-2","article-title":"Antinuclear antibody profiling in patients of a tertiary care centre in central India","volume":"36","author":"Gupta P","year":"2021","unstructured":"Gupta P, Agrawal P, Verma NR, Shah S, Patel S, Nanda R, Mohapatra E. Antinuclear antibody profiling in patients of a tertiary care centre in central India. Indian J Clin Biochem. 2021, 36:345-52. 10.1007\/s12291-020-00925-2","journal-title":"Indian J Clin Biochem"},{"key":"ref7","article-title":"Antinuclear antibodies and their detection in systemic lupus erythematosus (SLE)","volume":"10","author":"HO H","year":"1959","unstructured":"HO H, KU H. Antinuclear antibodies and their detection in systemic lupus erythematosus (SLE). Bull Rheum Dis. 1959, 10:197-8.","journal-title":"Bull Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(195910)2:5<468::aid-art1780020513>3.0.co;2-0","article-title":"Antinuclear antibodies in systemic lupus erythematosus","volume":"2","author":"Holman H","year":"1959","unstructured":"Holman H, Robbins W. Antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum. 1959, 2:468-71. 10.1002\/1529-0131(195910)2:5&lt;468::aid-art1780020513&gt;3.0.co;2-0","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin N","year":"2014","unstructured":"Agmon-Levin N, Damoiseaux J, Kallenberg C, et al.. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2014, 73:17-23. 10.1136\/annrheumdis-2013-203863","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8579-y","article-title":"Challenges in the standardization of autoantibody testing: a comprehensive review","volume":"53","author":"Tozzoli R","year":"2017","unstructured":"Tozzoli R, Villalta D, Bizzaro N. Challenges in the standardization of autoantibody testing: a comprehensive review. Clin Rev Allergy Immunol. 2017, 53:68-77. 10.1007\/s12016-016-8579-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref11","article-title":"Presentation of two bone marrow elements; the tart cell and the L.E. cell","volume":"23","author":"Hargraves MM","year":"1948","unstructured":"Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements; the tart cell and the L.E. cell. Proc Staff Meet Mayo Clin. 1948, 23:25-8.","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-195006000-00010","article-title":"Blood factor in acute disseminated lupus erythematosus; determination of gamma globulin as specific plasma fraction","volume":"219","author":"Haserick JR","year":"1950","unstructured":"Haserick JR, Lewis LA, Bortz DW. Blood factor in acute disseminated lupus erythematosus; determination of gamma globulin as specific plasma fraction. Am J Med Sci. 1950, 219:660-3. 10.1097\/00000441-195006000-00010","journal-title":"Am J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1949.65","article-title":"Normal bone marrow inclusion phenomena induced by lupus erythematosus plasma","volume":"13","author":"Haserick JR","year":"1949","unstructured":"Haserick JR, Bortz DW. Normal bone marrow inclusion phenomena induced by lupus erythematosus plasma. J Invest Dermatol. 1949, 13:47-9. 10.1038\/jid.1949.65","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF02157392","article-title":"Absorption of L. E. factor by isolated cell nuclei","volume":"10","author":"Miescher P","year":"1954","unstructured":"Miescher P, Fauconnet M. Absorption of L. E. factor by isolated cell nuclei. Experientia. 1954, 10:252-3. 10.1007\/BF02157392","journal-title":"Experientia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000478330","article-title":"New serological methods for the detection of the L. E. factor","volume":"2","author":"Miescher P","year":"1957","unstructured":"Miescher P, Str\u00e4ssle R. New serological methods for the detection of the L. E. factor. Vox Sang. 1957, 2:283-7. 10.1159\/000478330","journal-title":"Vox Sang"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1126\/science.126.3265.162","article-title":"Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein","volume":"126","author":"Holman HR","year":"1957","unstructured":"Holman HR, Kunkel HG. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science. 1957, 126:162-3. 10.1126\/science.126.3265.162","journal-title":"Science"},{"key":"ref17","article-title":"Demonstration by complement fixation the reaction between desoxyribonucleic acid and serum of patients with disseminated lupus erythematosus (Article in French)","volume":"245","author":"Seligmann M","year":"1957","unstructured":"Seligmann M, Milgrom F. Demonstration by complement fixation the reaction between desoxyribonucleic acid and serum of patients with disseminated lupus erythematosus (Article in French). C R Hebd Seances Acad Sci. 1957, 245:1472-5.","journal-title":"C R Hebd Seances Acad Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216259","article-title":"Role of ANA testing in the classification of patients with systemic lupus erythematosus","volume":"80","author":"Pisetsky DS","year":"2021","unstructured":"Pisetsky DS, Spencer DM, Rovin B, Lipsky PE. Role of ANA testing in the classification of patients with systemic lupus erythematosus. Ann Rheum Dis. 2021, 80:124. 10.1136\/annrheumdis-2019-216259","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux J","year":"2019","unstructured":"Damoiseaux J, Andrade LE, Carballo OG, et al.. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis. 2019, 78:879-89. 10.1136\/annrheumdis-2018-214436","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode M","year":"2018","unstructured":"Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance. Front Immunol. 2018, 9:609. 10.3389\/fimmu.2018.00609","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217166","article-title":"Terminology and definition of 'antinuclear antibodies': history and current debate","volume":"81","author":"Markewitz RD","year":"2022","unstructured":"Markewitz RD, Wandinger KP. Terminology and definition of 'antinuclear antibodies': history and current debate. Ann Rheum Dis. 2022, 81:186. 10.1136\/annrheumdis-2020-217166","journal-title":"Ann Rheum Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan EK","year":"2015","unstructured":"Chan EK, Damoiseaux J, Carballo OG, et al.. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015. Front Immunol. 2015, 6:412. 10.3389\/fimmu.2015.00412","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.68262","article-title":"Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario","volume":"53","author":"Sebastian W","year":"2010","unstructured":"Sebastian W, Roy A, Kini U, Mullick S. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario. Indian J Pathol Microbiol. 2010, 53:427-32. 10.4103\/0377-4929.68262","journal-title":"Indian J Pathol Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1338-5","article-title":"Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study","volume":"19","author":"Akmatov MK","year":"2017","unstructured":"Akmatov MK, R\u00f6ber N, Ahrens W, et al.. Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study. Arthritis Res Ther. 2017, 19:127. 10.1186\/s13075-017-1338-5","journal-title":"Arthritis Res Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12275","article-title":"Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey","volume":"122","author":"Sener AG","year":"2014","unstructured":"Sener AG, Afsar I, Demirci M. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey. APMIS. 2014, 122:1167-70. 10.1111\/apm.12275","journal-title":"APMIS"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.302.4276","article-title":"Determination of anti-nuclear antibody pattern distribution and clinical relationship","volume":"30","author":"Mengeloglu Z","year":"2014","unstructured":"Mengeloglu Z, Tas T, Kocoglu E, Aktas G, Karab\u00f6rk S. Determination of anti-nuclear antibody pattern distribution and clinical relationship. Pak J Med Sci. 2014, 30:380-3. 10.12669\/pjms.302.4276","journal-title":"Pak J Med Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.12.1131","article-title":"Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing","volume":"60","author":"Peene I","year":"2001","unstructured":"Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis. 2001, 60:1131-6. 10.1136\/ard.60.12.1131","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/345354-pattern-distribution-and-utility-of-reporting-anticellular-antibody-over-antinuclear-antibody-an-initial-report-from-the-immunofluorescence-laboratory-of-north-bengal-medical-college-and-hospital-west-bengal","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T06:32:22Z","timestamp":1747463542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/345354-pattern-distribution-and-utility-of-reporting-anticellular-antibody-over-antinuclear-antibody-an-initial-report-from-the-immunofluorescence-laboratory-of-north-bengal-medical-college-and-hospital-west-bengal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.84262","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}